Get started
Author

Isabel Falke

Observed names: Falke, I., Falke, Isabel
ORCID: 0000-0001-7845-6284
Observed ORCID: 0000-0001-7845-6284
OpenAlex ID: A5040117911
Dual Knockdown of Musashi RNA-Binding Proteins MSI-1 and MSI-2 Attenuates Putative Cancer Stem Cell Characteristics and Therapy Resistance in Ovarian Cancer Cells
2021 · Maria T. Löblein, Isabel Falke, et al. · International Journal of Molecular Sciences · 27
PDF
The Musashi RNA-binding proteins in female cancers: insights on molecular mechanisms and therapeutic relevance
2023 · Mark Sicking, Isabel Falke, et al. · Biomarker Research · 21
PDF
Knockdown of the stem cell marker Musashi-1 inhibits endometrial cancer growth and sensitizes cells to radiation
2022 · Isabel Falke, Fabian M. Troschel, et al. · Stem Cell Research & Therapy · 17
PDF
Low-Dose Total Skin Electron Beam Radiotherapy in Stage IB-IIB Mycosis Fungoides: Results From the Prospective S-MISR Study
2025 · Khaled Elsayad, Isabel Falke, et al. · JCO oncology advances. · 5
PDF
Radiotherapy for Other Nonmalignant Diseases
2025 · Isabel Falke, Ulrich Schäfer, et al. · Seminars in Radiation Oncology · 2
Physical and clinical results of a radiation bra in patients treated with total skin electron beam therapy
2024 · Isabel Falke, Khaled Elsayad, et al. · Physics and Imaging in Radiation Oncology · 1
PDF
Patient preferences and travel burden before radiotherapy for primary cutaneous lymphoma: baseline results from the S-MISR registry
2026 · David Rene Steike, Khaled Elsayad, et al. · Strahlentherapie und Onkologie
PDF
Radiotherapy for Merkel cell carcinoma: recommendations from the DEGRO Dermatooncology Working Group
2026 · Khaled Elsayad, Isabel Falke, et al. · Strahlentherapie und Onkologie
PDF
1034 Radiotherapy for primary cutaneous DLBCL: a collaborative analysis by the German Society of Radiation Oncology & Dermatological Oncology Working Group
2026 · Khaled Elsayad, Linda Agolli, et al. · Radiotherapy and Oncology
Favourable outcome after de-escalation of therapy in primary cutaneous DLBCL: a joint analysis of the German Society for Radiation Oncology (DEGRO) and the Cutaneous Lymphoma Working Group of the Dermatological Oncology Working Group (ADO)
2025 · Khaled Elsayad, Linda Agolli, et al. · European Journal of Cancer
598 Prognostic factors for low-dose total skin electron beam radiotherapy in stage IB - IIB mycosis fungoides
2025 · Khaled Elsayad, Isabel Falke, et al. · Radiotherapy and Oncology
1128 Patients’ prioritizing of quality or length of life and travel distance of primary cutaneous lymphoma patients referred to radiotherapy
2025 · Khaled Elsayad, David Rene Steike, et al. · Radiotherapy and Oncology
De-escalation of radiotherapy in primary cutaneous DLBCL leads to improved survival: a joint analysis by the German Society for Radiation Oncology (DEGRO) and the Working Group for Dermatological Oncology (ADO) Working Groups on Cutaneous Lymphomas
2025 · Elsayad, K., Agolli, L., et al. · RWTH Publications (RWTH Aachen)
Retrospective Evaluation of GEC-ESTRO Constraints for Definitive Radiochemotherapy with Brachytherapy and Correlation with Oncologic Outcome in Cervical Cancer: A Monocenter Study
2024 · Tom Schönicke, Raphael Koch, et al. · Cancers
PDF
Patients’ Prioritizing of Quality or Length of Life and Travel Distance of Primary Cutaneous Lymphoma Patients Referred to Radiotherapy: Baseline Results from the Prospective S-MISR Register
2024 · David Rene Steike, Khaled Elsayad, et al. · SSRN Electronic Journal
Works count: 18
Citation count: 73
H-index: 4
I10-index: 3
Year
Topic
Type